In the future, it will be crucial to collaborate with clinical experts to monitor circulating KLK8 levels in patients with diabetes-associated depression and investigate whether KLK8 levels correlate with DNA methylation levels in the KLK8 promoter region and the severity of depression symptomatology in diabetic patients. Here, KLK8 is linked to depressive symptom measurement.